Cardinal Health, Inc. (CAH)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
CEO:
Jason M. Hollar
Employees:
46,500
7000 CARDINAL PLACE, DUBLIN, OH 43017
6147573033

Cardinal Health, Inc. operates in two segments, Pharmaceutical and Medical. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.

Data derived from most recent annual or quarterly report
Market Cap 29.598 Billion Shares Outstanding277.06 Million Avg 30-day Volume 1.808 Million
P/E Ratio138.3324 Dividend Yield2.3027 EPS0.02
Price to Revenue0.1027 Debt to Equity-1.3404 EBITDA1.277 Billion
Price to Book Value0.0 Operating Margin0.2741 Enterprise Value22.405 Billion
Current Ratio0.989 EPS Growth1.159 Quick Ratio0.431
1 Yr BETA 0.4237 52-week High/Low 108.03 / 67.33 Profit Margin0.0747
Operating Cash Flow Growth-11.3427 Free Cash Flow to Firm (FCFF) TTM 2.841 Billion Free Cash Flow to Equity (FCFE) TTM267.143 Million
Altman Z-Score5.0954
Earnings Report2024-02-01
View SEC Filings from CAH instead.

View recent insider trading info

Cardinal Health, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CAH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CAH

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-12-05 by SNOW OLA M
  • 4: filed on 2023-12-05 by SCHERER MARY C.
  • 4: filed on 2023-12-05 by WEITZMAN DEBORAH
  • 4: filed on 2023-11-29 by WEITZMAN DEBORAH
  • 4: filed on 2023-11-16 by MAYER JESSICA L
  • 4: filed on 2023-11-16 by BRENNAN MICHELLE
  • 4: filed on 2023-11-16 by BARG STEVEN
  • 4: filed on 2023-11-16 by HALL PATRICIA HEMINGWAY
  • 4: filed on 2023-11-16 by CHANDRASEKARAN SUJATHA
  • 4: filed on 2023-11-16 by MUNDKUR CHRISTINE

    • Events (8k)

  • 8-K: filed on 2023-11-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-08:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-08-16:
  • 144: filed on 2023-08-17:
  • 144: filed on 2023-08-17:
  • 144: filed on 2023-08-17:
  • 144: filed on 2023-08-17:
  • 144: filed on 2023-08-17:
  • 144: filed on 2023-08-28:
  • 144: filed on 2023-11-27:
  • 144: filed on 2023-12-04:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    36.6 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    27.6 Thousand total shares from 3 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SNOW OLA M CHIEF HUMAN RESOURCES OFFICER

    • Officer
    		 24,981 2023-12-01 2

    WEITZMAN DEBORAH CEO, PHARMACEUTICAL SEGMENT

    • Officer
    		 34,564 2023-12-01 5

    SCHERER MARY C. CHIEF ACCOUNTING OFFICER

    • Officer
    		 10,432 2023-12-01 4

    KENNY GREGORY B

    • Director
    		 59,680 2023-11-15 1

    MUNDKUR CHRISTINE

    • Director
    		 4,739 2023-11-15 1

    EVANS DAVID C

    • Director
    		 12,576 2023-11-15 1

    EDISON SHERI H.

    • Director
    		 12,051 2023-11-15 1

    JOHRI AKHIL

    • Director
    		 20,071 2023-11-15 1

    HALL PATRICIA HEMINGWAY

    • Director
    		 29,467 2023-11-15 1

    KILLEFER NANCY

    • Director
    		 24,827 2023-11-15 1

    CHANDRASEKARAN SUJATHA

    • Director
    		 4,739 2023-11-15 1

    MAYER JESSICA L CHIEF LEGAL/COMPLIANCE OFFICER

    • Officer
    		 79,680 2023-11-15 4

    BRENNAN MICHELLE

    • Director
    		 5,289 2023-11-15 1

    BARG STEVEN

    • Director
    		 4,739 2023-11-15 1

    ALT AARON E CHIEF FINANCIAL OFFICER

    • Officer
    		 29,319 2023-08-16 3

    HOLLAR JASON M. CHIEF EXECUTIVE OFFICER

    • Officer
    		 214,811 2023-08-15 3

    MASON STEPHEN M CEO, MEDICAL SEGMENT

    • Officer
    		 37,355 2023-08-15 2

    GREENE MICHELLE D. CHIEF INFORMATION OFFICER

    • Officer
    		 20,814 2023-08-15 2

    DOWNEY BRUCE

    • Director
    		 52,729 2023-06-30 1

    COX CARRIE SMITH

    • Director
    		 41,631 2022-11-09 0

    SCARBOROUGH DEAN A

    • Director
    		 6,659 2022-10-18 0

    CRAWFORD VICTOR L. CEO, PHARMACEUTICAL SEGMENT

    • Officer
    		 105,699 2022-08-15 0

    KAUFMANN MICHAEL C CEO

    • Officer
    • Director
    		 601,075 2022-08-15 0

    HOLCOMB MICHELE EVP - STRATEGY & CORP. DEV.

    • Officer
    		 44,491 2022-08-15 0

    RICE BRIAN S CHIEF INFORMATION OFFICER

    • Officer
    		 37,850 2022-08-15 0

    ENGLISH PATRICIA M CHIEF ACCOUNTING OFFICER

    • Officer
    		 9,000 2022-08-15 0

    WEILAND JOHN H

    • Director
    		 11,138 2021-11-11 0

    LOSH J MICHAEL

    • Director
    		 7,264 2021-10-15 0

    DARDEN CALVIN

    • Director
    		 39,616 2020-11-09 0

    LAWS STUART G SVP & CHIEF ACCOUNTING OFFICER

    • Officer
    		 12,289 2020-08-15 0

    ARNOLD COLLEEN F.

    • Director
    		 35,103 2019-11-12 0

    GIACOMIN JON L CEO, MEDICAL SEGMENT

    • Officer
    		 No longer subject to file 2019-08-15 0

    MORFORD CRAIG S CHIEF LEGAL/COMPLIANCE OFFICER

    • Officer
    		 126,301 2018-12-03 0

    GOMEZ JORGE M CHIEF FINANCIAL OFFICER

    • Officer
    		 39,582 2018-11-08 0

    MORRISON PATRICIA CHIEF INFORMATION OFFICER

    • Officer
    		 No longer subject to file 2018-08-31 0

    BARRETT GEORGE S EXECUTIVE CHAIRMAN

    • Officer
    • Director
    		 502,630 2018-08-15 0

    KIMMET PAMELA O. CHIEF HUMAN RESOURCES OFFICER

    • Officer
    		 22,612 2018-08-15 0

    ANDERSON DAVID J

    • Director
    		 0 2018-01-16 0

    JONES CLAYTON M

    • Director
    		 14,964 2017-11-08 0

    KING DAVID P

    • Director
    		 21,044 2017-11-08 0

    CASEY DONALD M JR. CEO, MEDICAL SEGMENT

    • Officer
    		 146,503 2017-09-15 0

    WATKINS CAROLE S CHIEF HR OFFICER

    • Officer
    		 33,994 2016-05-20 0

    STEPHEN FALK T EVP, GEN. COUNSEL & CORP. SEC.

    • Officer
    		 32,455 2015-11-30 0

    FITZGERALD MEGHAN EVP, STRATEGY & HEALTH POLICY

    • Officer
    		 16,760 2015-11-17 0

    NOTEBAERT RICHARD C

    • Director
    		 35,778 2015-03-03 0

    BLAKE MARK R EVP - STRATEGY & CORP. DEV.

    • Officer
    		 20,409 2014-11-07 0

    FINN JOHN F

    • Director
    		 No longer subject to file 2014-11-05 0

    HENDERSON JEFFREY WILLIAM CHIEF FINANCIAL OFFICER

    • Officer
    		 67,190 2014-08-27 0

    BRITT GLENN

    • Director
    		 0 2014-05-07 0

    SPAULDING JEAN G

    • Director
    		 No longer subject to file 2013-11-06 0

    LYNCH MICHAEL A CEO, MEDICAL SEGMENT

    • Officer
    		 227,098 2012-02-27 0

    RAISBECK DAVID W

    • Director
    		 17,075 2011-11-02 0

    MONGAN JAMES J MD

    • Director
    		 7,150 2010-11-03 0

    CLARK R KERRY FORMER CHAIRMAN AND CEO

    • Officer
    • Director
    		 No longer subject to file 2009-09-01 0

    OHALLERAN MICHAEL D

    • FORMER DIRECTOR
    		 No longer subject to file 2009-08-31 0

    SCHLOTTERBECK DAVID L

    • FORMER VICE CHAIR & CEO CTS
    		 No longer subject to file 2009-08-31 0

    FRANCIS PHILIP L

    • Director
    		 No longer subject to file 2009-08-31 0

    FONG IVAN K

    • FORMER CLO & SECRETARY
    		 No longer subject to file 2009-05-15 0

    CONRADES GEORGE H

    • Director
    		 2,653 2008-11-05 0

    MCCOY JOHN B

    • Director
    		 84,367 2008-11-05 0

    WALTER ROBERT D

    • Director
    		 4,307,853 2008-10-06 0

    JAIN VIVEK EVP - CORP. DEV. & STRATEGY

    • Officer
    		 39,594 2008-09-26 0

    WALTER MATTHEW D

    • Director
    		 No longer subject to file 2008-01-07 0

    WALSH DANIEL J EVP, CHF ETHCS & COMPL OFFCR

    • Officer
    		 13,125 2007-11-26 0

    PARRISH MARK W CEO - HSCS

    • Officer
    		 70,666 2007-09-02 0

    SLUSSER ERIC EVP, CAO & CONTROLLER

    • Officer
    		 8,575 2007-06-04 0

    HAVENS JOHN F

    • Director
    		 35,759 2006-09-14 0

    FORD BRENDAN A EVP-CORPORATE DEVELOPMENT

    • Officer
    		 96,018 2006-05-03 0

    LABRUM RONALD K CEO-HEALTHCARE SUPPLY CHN SVC

    • Officer
    		 44,668 2006-02-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SNOW OLA M - Officer CHIEF HUMAN RESOURCES OFFICER

    		2023-12-05 16:46:47 -0500 2023-12-01 F 382 $107.08 d 24,842 direct 0.4817 0.4817 2 0.0 1

    SCHERER MARY C. - Officer CHIEF ACCOUNTING OFFICER

    		2023-12-05 16:44:54 -0500 2023-12-01 F 217 $107.08 d 10,432 direct 0.4817 0.4817 2 0.0 1

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-12-05 16:42:35 -0500 2023-12-01 F 638 $107.08 d 34,564 direct 0.4817 0.4817 2 0.0 1

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 S 36,642 $106.31 d 35,202 direct yes 1.6904 0.5413 2.0513 4 0.0 1

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 M 15,373 d 0 direct yes

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 M 15,373 $66.43 a 71,844 direct yes 1.6904 0.5413 2.0513 4 0.0 1

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 M 6,279 d 0 direct yes

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 M 6,279 $83.19 a 56,471 direct yes 1.6904 0.5413 2.0513 4 0.0 1

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 M 5,990 d 0 direct yes

    WEITZMAN DEBORAH - Officer CEO, PHARMACEUTICAL SEGMENT

    		2023-11-29 09:14:46 -0500 2023-11-27 M 5,990 $84.27 a 50,192 direct yes 1.6904 0.5413 2.0513 4 0.0 1

    MAYER JESSICA L - Officer CHIEF LEGAL/COMPLIANCE OFFICER

    		2023-11-16 16:32:09 -0500 2023-11-15 F 5,185 $102.90 d 79,680 direct 1.8087 3.1531 3.1531 6 0.0 1

    EDISON SHERI H. - Director

    		2023-11-16 16:22:06 -0500 2023-11-15 A 1,965 a 12,051 direct 1.8087 3.1531 3.1531 6 0.0 1

    BRENNAN MICHELLE - Director

    		2023-11-16 16:31:06 -0500 2023-11-15 A 1,965 a 5,289 direct 1.8087 3.1531 3.1531 6 0.0 1

    BARG STEVEN - Director

    		2023-11-16 16:30:03 -0500 2023-11-15 A 1,965 a 4,739 direct 1.8087 3.1531 3.1531 6 0.0 1

    HALL PATRICIA HEMINGWAY - Director

    		2023-11-16 16:29:04 -0500 2023-11-15 A 1,965 a 29,467 direct 1.8087 3.1531 3.1531 6 0.0 1

    CHANDRASEKARAN SUJATHA - Director

    		2023-11-16 16:27:48 -0500 2023-11-15 A 1,965 a 4,739 direct 1.8087 3.1531 3.1531 6 0.0 1

    MUNDKUR CHRISTINE - Director

    		2023-11-16 16:26:45 -0500 2023-11-15 A 1,965 a 4,739 direct 1.8087 3.1531 3.1531 6 0.0 1

    KILLEFER NANCY - Director

    		2023-11-16 16:25:47 -0500 2023-11-15 A 1,965 a 24,827 direct 1.8087 3.1531 3.1531 6 0.0 1

    JOHRI AKHIL - Director

    		2023-11-16 16:24:51 -0500 2023-11-15 A 1,965 a 20,071 direct 1.8087 3.1531 3.1531 6 0.0 1

    KENNY GREGORY B - Director

    		2023-11-16 16:23:45 -0500 2023-11-15 A 3,193 a 59,680 direct 1.8087 3.1531 3.1531 6 0.0 1

    EVANS DAVID C - Director

    		2023-11-16 16:22:59 -0500 2023-11-15 A 1,965 a 12,576 direct 1.8087 3.1531 3.1531 6 0.0 1

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CARDINAL HEALTH INC CAH 2023-12-08 22:15:04 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 21:45:04 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 21:15:04 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 20:45:04 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 20:15:07 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 19:45:04 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 19:15:03 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 18:45:03 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 18:15:04 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 17:45:03 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 17:15:03 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 16:45:05 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 16:15:04 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 15:45:04 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 15:15:04 UTC 5.07 0.25 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 14:45:04 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 14:15:03 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 13:45:03 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 13:15:04 UTC 4.9119 0.4081 8200000
    CARDINAL HEALTH INC CAH 2023-12-08 12:45:05 UTC 4.9119 0.4081 8200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    TRANSAMERICA FUNDS- Transamerica Long/Short Strategy CAH -705.0 shares, $-36103.05 2020-01-31 N-PORT
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund CAH -436.0 shares, $-23352.16 2020-12-31 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund CAH -70.0 shares, $-3355.8 2020-03-31 N-PORT
    UBS RELATIONSHIP FUNDS- UBS U.S. EQUITY ALPHA RELATIONSHIP FUND CAH -21918.0 shares, $-1143900.42 2020-06-30 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund CAH -102.0 shares, $-6196.5 2021-03-31 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund CAH -2239.0 shares, $-204801.33 2023-07-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments